What is the concern about Singulair (montelukast)?
Singulair is a major drug in asthma treatment – it is important to review recent developments and put these findings in perspective of overall asthma care for individual patients.
Singulair (montelukast)
Singulair (manufactured and marketed by Merck and Co.) is a drug of the so-called anti-leukotriene class that is used for control of symptoms of asthma and allergic rhinitis (hay fever). It was initially approved by the U.S. Food and Drug...
My e-mail is buzzing. "Have you seen the news about Singulair? Are you worried?" The short answer is, "No, I'm not concerned at all." ... Read more »
Did you see the reports last week that Singulair was going to be investigated by the Food and Drug Administration for reports of a "casual... Read more »
The FDA has announced it is investigating a possible association between the use of Singulair and behavior/mood changes, suicidality... Read more »
The Food and Drug Administration has approved Singulair to prevent exercise-induced asthma (EIA) in patients ages 15 years and older. EIA is a... Read more »
This is a study to evaluate the treatment of patients entering emergency rooms with asthma attacks when they are given an intravenous form of MK0476... Read more »
This is a study to compare the effects of Flovent (fluticasone propionate), Advair (fluticasone propionate/salmeterol), and Singulair (montelukast)... Read more »
The U.S. Food and Drug Administration (FDA) has requested that asthma drugs in the leukotriene receptor agonists category be given a "precaution" on... Read more »
Easing asthma symptoms with an albuterol inhaler may not work over a long period of time, says Dr. Norma Nehren. Albuterol is intended as a rescue... Read more »